Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3771104012 | Ipratropium and salbutamol only product in pulmonary dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3771105013 | Product containing only ipratropium and salbutamol in pulmonary dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3771106014 | Albuterol and ipratropium only product in pulmonary dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing only ipratropium and salbutamol in pulmonary dose form (medicinal product form) | Has manufactured dose form | Pulmonary dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing only ipratropium and salbutamol in pulmonary dose form (medicinal product form) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing only ipratropium and salbutamol in pulmonary dose form (medicinal product form) | Is a | Salbutamol + Ipratropium | true | Inferred relationship | Existential restriction modifier | ||
Product containing only ipratropium and salbutamol in pulmonary dose form (medicinal product form) | Is a | Product containing ipratropium and salbutamol in pulmonary dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing only ipratropium and salbutamol in pulmonary dose form (medicinal product form) | Has active ingredient | Salbutamol | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing only ipratropium and salbutamol in pulmonary dose form (medicinal product form) | Has active ingredient | Ipratropium | true | Inferred relationship | Existential restriction modifier | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely ipratropium bromide 167 microgram/1 milliliter and salbutamol (as salbutamol sulfate) 833 microgram/1 milliliter conventional release solution for inhalation (clinical drug) | Is a | True | Product containing only ipratropium and salbutamol in pulmonary dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
Product containing precisely ipratropium bromide 200 microgram/1 milliliter and salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) | Is a | True | Product containing only ipratropium and salbutamol in pulmonary dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets